(State or other Jurisdiction of Incorporation or Organization) | (Commission File Number) | (IRS Employer Identification No.) |
(Address of Principal Executive Offices) | (zip code) |
(Registrant’s telephone | ||
number, including area code) |
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
The
|
|
|
The
|
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Item 9.01
|
Financial Statements and Exhibits
|
Exhibit
Number
|
Description
|
|
10.1
|
||
104
|
Cover Page Interactive Data File formatted in Inline XBRL
|
Cyclo Therapeutics, Inc. | |||
Date: August 21, 2023 | |||
By: | /s/ N. Scott Fine | ||
N. Scott Fine | |||
Chief Executive Officer |
SFZF$PN?HV&PVG53(:#T\1QD;&V$"EWR:U2F:;N! - M']\Y^8I0-#.*YI$4$ZZ$M/GG$\CB0B!<*LNZLK1K96RMHZ(XBCRI8JG2O*N2 MJ0$\(A49RB0R:@/??B$NKCY^1!#;&6+[*,1K$7 R3L(Y5T4DN(CC.">TV6BU M$*!.!M0Y"FC&7LG(A\"*A?"V!7L8#Y=LGIW4'7K6;F Q/1_JT!HSY-U,KHM-&=?[ M OV9ZQ<1!!SCV^L:[OOXLL*8*/DB(J]P+DM$KV\QMKQAN*B]_\PVD=JP@/PM MXH/E6B)9IZTFEH%NWAS<$E.W<1S ^NDP"BY0[V"EZN8=P,4M_%9Z,">3E8PP M\R@1:;B=DX[3 1-P<9^> MRD!XPHAH2>X@OY5@02$/KE+*DSN^B[OU1/$3#Z:'0X&EBZ(9CWRNR/UB<2!^ MN%XI66[]+F[4/Y&-M$Z K!00ERT%S+W?/<[\KT*NEC:@7T "3!NR+6;1II - M5RQCH[G;4]R=!S!C?CIKUP%;%BYH<8%2E-S8Z7'&/@0:!08Q@O"]DJ^\<()* MM&!MX9Q12AMM#&WO10 W8>L+,IH:Z3U/F'ID0<+A!BZL': \3%+?XF3"PO)0+XM+?YW^0*?<2\.GB M=,"5MO$C:0"K)&:*O-@8DE]/;1A)##:A;2 Q[+R94+P'S!3S;95/-^%<%IIV MB<#P^^P&(\E[""WI(;L9(U>OWHI%2W[P=;!$:#R87@[^PICR/D)QWW]BRKZ8 MZIF<) JH[*Y&5EQ'%1*J_]&DS+L-[7Q"(:&MYJ/,>0.B>+MX3R'A2F_1(T:2 M>!<_LE]=V"Y&WI3J>$\IKZ 2 5M!3QA*WI3J>",YOH1*A Z74&UO"\UN1]XQ MNTK0). +4').V^ 6:KO#MSTQ,DYWU>;20+&DARO.8*UC+X#_%U*:MQ.[49?M ML_;_ U!+ P04 " (0!57GZ ;\+$" #B# #0 'AL+W-T>6QE O%DN7/ZZZ>S;"=I M=67=A['-H N6/O.-%Q[ MI#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4 M!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K XU7=>&18/QA<0&>7=J?$,:\M. MB^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4 M?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_& M?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQ MY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7 M^2V,D_'T7!S1JP,Z6PEY7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJ MOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD \%G'!QR>(W?#$T % M^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%N MXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI" M5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ; 4/2 M='@//GL?)=-[*CG_5U/\!%!+ P04 " (0!57EXJ[', 3 @ "P M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6= MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6' MTD!$VV-#L%HL/D N&6:WO606IW.D5XA -/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0 ( A %5 &PO=V]R:V)O;VLN>&ULC5%=:\,P#/PKQC]@2 0SH\0RVT+E6J:'3"T4\4V#C-E4DYPH] M&09;B(S5'WC3B?PT9>H1-N6'$2&%GN5"6&-,W&_T_$8T'D&6A^[ ](2.(2X- MPW.D0XMAU]&(B^S"1I_#6(<0Y_$_,5)=8P5+J@X> @\Y1G"=P) :;)-6P7@H M]+BB[H-5CX$E)+4* Y7L=D[E],H.KEGD7F08YRB#N+*#\%&MA1H#V# :;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$% @ "$ 55R0> MFZ*M ^ $ !H !X;"]? +7_OR4Z?:!1W M;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9 MHIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJ MEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0 ( A M%5=ED'F2&0$ ,\# 3 6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"% MKQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/ M$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4 MZ]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N M6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC M JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@A MLO7L^T%.6X.^D &PO=&AE M;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( A %5>V^";J\00 ',5 8 M " @0P( !X;"]W;W)K &PO 7BKL &PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " (0!5799!YDAD! #/ P M$P @ %*$P 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 .."0 ) #X" "4% ! end